Nektar(NKTR) - 2024 Q1 - Earnings Call Transcript

Nektar Therapeutics, Inc. (NASDAQ:NKTR) Q1 2024 Earnings Conference Call May 9, 2024 5:00 PM ET Company Participants Vivian Wu - Associate Director, Investor Relations and Corporate Affairs Howard Robin - President, CEO & Director Jonathan Zalevsky - Chief Research & Development Officer Jennifer Ruddock - Chief Business Officer Mary Tagliaferri - Chief Medical Officer Conference Call Participants Jay Olson - Oppenheimer Roger Song - Jefferies Andy Hsieh - William Blair & Company Arthur He - H.C. Wainwright ...